Loading
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 15 May 2026 for Enhabit, Inc., €3.1M. Read the official filing
Filing timeline
BuySaleBarbara Ann Jacobsmeyer
Insider track record
Disclosed buys
1
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Barbara Ann Jacobsmeyer: trading record in brief
Barbara Ann Jacobsmeyer (chief executive) discloses dealings in 2 companies, chiefly Enhabit, Inc. and Encompass Health Corp. We count 25 filings; the first trade dates from 3 January 2022 and the latest from 15 May 2026.
The open-market record is one-sided, with 1 purchase worth €405k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 17 share grants.
Most recently, on 15 May 2026, the filings show a share grant worth €3.1M in Enhabit, Inc. The clock since the last published purchase (10 August 2022) now reads 1,530 days. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Barbara Ann Jacobsmeyer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations25 total
263,237 shares@ US$13.800.52% mcap11.6% of flowCommon StockSEC:0001691132-26-000006:3
340,530 shares@ US$13.800.67% mcap15.1% of flowCommon StockSEC:0001691132-26-000006:5
263,237 shares@ US$13.800.52% mcap11.6% of flowCommon StockSEC:0001691132-26-000006:4
340,530 shares@ US$13.800.67% mcap15.1% of flowCommon StockSEC:0001691132-26-000006:6
65,964 shares@ US$13.800.13% mcap2.9% of flowCommon StockSEC:0001691132-26-000006:1
127,129 shares@ US$13.800.25% mcap5.6% of flowCommon StockSEC:0001691132-26-000006:2
413,614 shares@ US$13.800.81% mcap50.0% of flowCommon StockSEC:0001691132-26-000006:0
32,789 shares@ US$13.611.6% of flowCommon StockSEC:0001691132-26-000004:0
46,504 shares@ US$13.582.2% of flowCommon StockSEC:0001691132-26-000002:0
25,957 shares@ US$7.880.7% of flowCommon StockSEC:0001803737-25-000125:0
27,822 shares@ US$8.020.7% of flowCommon StockSEC:0001803737-25-000057:0
17,997 shares@ US$8.370.5% of flowCommon StockSEC:0001803737-25-000043:0
7,973 shares@ US$8.260.2% of flowCommon StockSEC:0001803737-25-000031:0
10,746 shares@ US$7.810.3% of flowCommon StockSEC:0001803737-25-000007:0
114,302 shares@ US$8.813.3% of flowCommon StockSEC:0001803737-24-000022:0
789 shares@ US$9.490.0% of flowCommon StockSEC:0001803737-24-000017:0
9,928 shares@ US$10.350.3% of flowCommon StockSEC:0001803737-24-000002:0
18,881 shares0Common StockSEC:0001803737-23-000061:0
2,154 shares0Common StockSEC:0001803737-23-000067:0
35,001 shares0Common StockSEC:0001803737-23-000034:0
30,000 shares@ US$13.781.4% of flowCommon StockSEC:0001803737-22-000090:0
Canonical exit: 7 Nov 2022 (T+90)
28,691 shares0Common StockSEC:0001803737-22-000063:0
584 shares@ US$65.5211.5% of flowEncompass Health Common StockSEC:0001127602-22-006968:0
1,048 shares@ US$65.9120.8% of flowEncompass Health Common StockSEC:0001127602-22-006349:0
3,455 shares@ US$65.2667.6% of flowEncompass Health Common StockSEC:0001127602-22-000853:0
25 of 25 declarations
